Skip to content
OpenCapital
Get started

Axogen AXGN Sales & Marketing

Sales & Marketing at other companies

LeMaitre Vascular logo
LeMaitre VascularLMAT
$14.52M+2.1%

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.26B+110%

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%—
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's sales & marketing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's sales & marketing?
Axogen (AXGN) reported sales & marketing of $28.63M in Q1 2026.
How has Axogen's sales & marketing changed year-over-year?
Axogen's sales & marketing increased by 36.1% year-over-year, from $21.05M to $28.63M.
What is the long-term trend for Axogen's sales & marketing?
Over 4 years (2021 to 2025), Axogen's sales & marketing has grown at a 7.4% compound annual growth rate (CAGR), from $73.33M to $97.74M.
What does sales & marketing mean?
Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.